What are the benefits to me of repositing my strain with the MMRRC?
There are a number of benefits to you, the donor, of having the MMRRC preserve and distribute your strain:
Fulfills your obligation to share biomedical research resources developed under NIH funded grants.
Frees up animal housing resources.
Reduces per diem costs.
Preserves and maintains your strain in a cryopreserved archive.
Eliminates the shipment of mice to multiple requesting investigators.
What is required to submit a candidate strain to the MMRRC?
The Donating Investigator (DI) must read and agree to the MMRRC
terms and conditions and complete the web-based application
form. Generally, a published reference or a preprint is
required. Once the strain is accepted, the DI must provide
additional breeding and husbandry information and a genotyping
protocol (or phenotyping method). Additionally, they need to
submit MMRRC's Donor Material Transfer Agreement
signed by the DI and an authorized official of their institution
(e.g., a Technology Transfer Coordinator), and provide
a recent Health Status Report for the strain's
colony. (See Overview of
Strain Submission Process for additional information.)
How can I protect my Intellectual Property rights by preventing distribution to For Profit organizations without my permission?
The donating investigator (or their institution's Technology Transfer official) may elect to limit MMRRC distribution of their strain to non-profit or academic institutions by selecting this option on the MMRRC's Donor MTA form. The MMRRC will not knowingly distribute or ship such strains to any commercial entity, but will refer inquires from such for-profit entities back to the donor and their institution in order to obtain the material.
Who reviews my strain submission?
The MMRRC's Coordinating Committee (CC) makes the
decision based on information in the application and any
provided papers. The MMRRC considers input from members of its
Advisory Panel who
have specialized expertise. The AP members are provided with
the same information as the CC members.
Does the MMRRC create new strains for distribution?
Generally, no. The MMRRC is a repository and distributor for strains developed
primarily by researchers. The MMRRC considers candidate strains submitted
by researchers for preservation and distribution. Those determined
to have sufficient or potential scientific value are accepted
for importation, maintenance and distribution by the
system. The MMRRC facilities on request will generate chimeric mice from
ES cell lines, constituting a new genetic line. Occasionally, an MMRRC
facility creates a new mouse line, either by traditional breeding methods
or micro-injection of ES cell line; in order to make these lines available
to other researchers these are also added to the repository.
How long does it take for a strain to become available for
distribution?
Generally, about six to nine months; a number of factors
affect the total time, including:
time to obtain information about the candidate strain;
time to conduct the review;
time for the Donating Investigator to provide the
necessary documents and ship the mice;
time to import, genotype and cryopreserve the strain.
Once a strain is accepted and all information provided, the MMRRC facility
assigned to preserve and distribute the strain must acquire
the strain from the Donating Investigator. Usually only a few
mice are provided, and the time can vary considerably. In
order to minimize pathogen transfer and colony contamination,
the mice must be rederived. Afterwards, the mice must be bred
to a sufficient colony size to allow cryopreservation. For a
live colony, the colony must be expanded to a level
sufficient to support distribution.
Do I need to have a published paper before submitting my
strain to the MMRRC?
Generally, yes; preprints are acceptable. For the strain to
be valuable for the research community, other researchers must
be able to learn about the research involving your strain.
Strains without publications are unlikely to be requested for
distribution. Since the capacity of the repository is limited,
the MMRRC looks for strains that the research community may
find valuable. Under Contract
Strain Management submissions (Type-3), the MMRRC review
board may waive the publication requirement.
I have not yet published my research about my new strain and
am not ready to release my strain to others. Will the MMRRC
still consider taking my strain?
Yes. Although the MMRRC prefers published strains, to encourage investigators to submit their valuable
strains we offer a Delayed Release
option. As the Donating Investigator, you may request Delayed
Release by briefly explaining your need on your submission
application. If your
submission is accepted, the MMRRC can delay release of your
strain until your publication date for a maximum of 12
months. You must inform
the MMRRC of the date of publication on or
before publication date. Pursuant to NIH policy, the
MMRRC will make your strain available as soon as feasible
after the delay period. (For more information, see Delayed Release page.)
What is a COU?
The abbreviation stands for Conditions of Use. It is an agreement between a provider and a recipient for transfer of materials. The MMRRC uses the COU as the formal instrument for transferring material from the MMRRC to Recipients. The COU states the terms and use limitations imposed by the provider on the recipient. See MMRRC's COU for additional information.
When I obtained material from the MMRRC, I agreed to acknowledge the donor of the strain in any of my publications or preesentations. How can I find out who the donor is of this strain?
The abbreviation stands for Material Transfer Agreement.
It is an agreement between a provider and a recipient for transfer
of materials. The MMRRC uses MTAs as the formal instrument for
transferring mouse strains from Donors to the MMRRC. Note, some of the collections require a signed User Agreement for transfer of material from the MMRRC to Recipients although they are not formally called MTAs. The MTA states the terms and use limitations
imposed by the provider on the recipient. (See MMRRC MTAs for additional information.)
Why are there separate User agreements for the Deltagen and Lexicon Genetics mice?
Under the terms of the NIH contracts with Deltagen, Inc. and Lexicon Genetics, Inc.
each corporation established its own mechanisms for licensing these strains
to non-profit and academic recipients. The MMRRC was not involved in establishing
these agreements and acts only as an intermediary in obtaining the necessary agreements
so that the research community has access to these research mice.
The signatorees to these agreements are the recipient and the donor corporation and the MMRRC is not authorized to negotiate any alterations to the agreement terms.
Can I alter the terms of the MMRRC MTA to address
concerns of my institution's technology transfer official?
No. Custom written MTAs and alterations to the
MMRRC MTAs would create much confusion and additional administrative
burdens on the MMRRC and other parties in the distribution process,
thus impeding the acquisition and distribution of strains for the
research community. These MTAs were developed from extensive consultation
among the technology transfer professionals of the MMRRC facilities.
We believe the current MTAs are effective agreements for sharing
of these research resources which achieve the appropriate balance for both the donor
and the recipient. (See MMRRC MTAs for additional
information.)
What if I want to apply for a Type 1 submission but would like
to request that a certain MMRRC facility be the distributor?
Complete the submission form as a Type 1, and e-mail your
request for a specific distribution MMRRC facility to the
MMRRC's Strain Donation Coordinator (sacoord@mmrrc.org). The
MMRRC Submission Review group will consider such requests once
the strain is accepted. The Review group must balance the
needs of the entire MMRRC repository and so cannot guarantee
the requested assignment.
Who can request mice from the MMRRC?
The MMRRC's purpose is to provide these strains to
bona fide biomedical researchers. Therefore, most
recipients will be associated with a recognized biomedical or
genetics research institution. All recipients are required to
conform their research to all applicable statues and
regulations, including all applicable federal statutes and
Public Health Service policies relating to the use and care of
laboratory animals. The donating investigator or their
institution may have restricted distribution of their strain
to non-profit institutions. The MMRRC's Strain Catalog
and Strain Detail Sheets indicate this restriction where
applicable.
How are these strains priced?
The MMRRC's Coordinating Committee adopted a uniform
distribution fee structure for the MMRRC. Each MMRRC facility
charges the same fees for live mice, resuscitated live mice and
cryopreserved materials. Each MMRRC facility sets its own fees
for additional services, shipping and any special handling or
procedures requested by the recipient.
What does the cryo-recovery fee cover?
The distribution fee covers the expense of resuscitating mice from the cryo-archive; you will receive the resulting litter. The litter will contain at minimum one mutant carrier; the actual number of animals and the gender and genotype ratios will vary. (Typically, multiple breeder pairs can be established from the recovered litter.) Prior to shipment, the MMRRC will provide information about the animals recovered. If you anticipate or find that you need to request specific genotypes, genders or quantities of mice in excess of what is likely from a resuscitated litter, you may discuss available options and pricing with the supplying MMRRC facility.
How long does it take to resuscitate a strain from cryo-recovery?
Recovered litters are usually available to ship in 3 to 4 months after an order is placed and a Conditions of Use form or other User Agreement has been received. Please view our Resuscitation Timeline for more details.
If I request additional mice after receiving mice through a
cryo-recovery, must I pay an additional cryo-recovery fee?
That depends on the continued availability of a live breeding
colony. Since the recovered litter is transferred to the
requesting investigator, normally there would not be
additional animals available -- unless the facility is breeding
more animals to replenish the cryo archive.
The MMRRC's
Informatics, Coordination and Service Center
can assist
you in determining the status of a live colony following
cryo-recovery.
Why is the maximum number of mice that can be requested at one
time so small?
The MMRRC is not a commercial breeding facility and the
strains in the repository are not in high enough demand to
warrant a large production colony. To assure availability to
other interested researchers, the MMRRC limits requests to two
pair of breeders, leaving the recipient to breed up a colony
sufficient for their research needs.
Can I request more than the numbers specified in the standard
availability level?
The MMRRC's
Informatics, Coordination and Service Center
will take your
request for consideration by the supplying MMRRC facility. It is
up to the supplying MMRRC facility to determine whether they
can fulfill your request for additional animals.
Can I request large quantities of MMRRC mice?
No, but at its discretion, the MMRRC facility may
negotiate with you or your institution to establish a
contractual custom breeding colony for a fee. The
arrangements are negotiated directly with the supplying
MMRRC facility; such special breeding colonies must not impede the
availability of the strain to other researchers.
Is it possible to obtain cryopreserved material from the
MMRRC instead of live mice?
Yes, if the distributing MMRRC facility offers this product
form. When available, the MMRRC Strain Catalog lists the forms
of cryo-material that can be requested. The individual MMRRC
facilities determine which strains they will provide as
cryo-material.
How do I obtain assistance with biological, husbandry,
breeding or genotyping questions for a particular strain?
Each MMRRC facility provides technical services for the strains
available from their facility. The MMRRC's Customer Service
Center (800-910-2291 in North America or 530-757-5710) can
direct your call to the appropriate facility's technical
services. You may also select from the menu on the left edge of the Members page to
contact a facility directly.
How can I obtain live mice from a repository in another country or region?
As a member of Federation
of International Mouse Resources (FIMRe)
, the MMRRC is able to assist you with obtaining live mice at your institution.
FIMRe members can exchange cryopreserved mouse materials for reanimation by another repository and subsequent
delivery of live animals.
As a U.S. researcher, how can the MMRRC assist me in importing mice from an overseas repository?
Generally, cryopreserved materials are easier to export and import than live animals and the member repositories
are familiar with the regulations and procedures affecting transfers between repositories, saving you
and your institution this effort. Member FIMRe repositories will ship the requested cryopreserved material to the
MMRRC facility of your choice. The MMRRC will reanimate the material and ship the recovered mice to your institution.
Additionally, you may contract with the MMRRC for any additional services you may require including genotyping or additional
breeding for specific quantities or genotypes of animals.
As a researcher in another country, how best can I obtain MMRRC mice as live animals?
If you or your institution is able to reanimate live mice from cryopreserved materials, you may request
distribution as cryopreserved material. If you are not able to perform the reanimation, you may arrange
with a FIMRe member repository to perform the reanimation for you and with the MMRRC to have cryopreserved
materials shipped to the member repository of your choice for reanimation.
When obtaining mice via an affiliated FIMRe repository, are there additional restrictions or limitations placed on the mice.
Distributions utilizing this reanimation service are governed by all regulations, licenses, terms of use, policies, etc.
applicable to the mouse line at the originating repository. Recipients will obtain any licenses, MTA's, etc. required by the
originating repository; the reanimating repository does not place additional restrictions or conditions on use of the mice.
The MMRRC is a collaborative effort, funded by grants from the
NIH
This site requires JavaScript. Tested for Firefox 3.5+, Microsoft Internet Explorer 7+,
Google Chrome.